These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24139369)

  • 1. Adherence to a five day treatment course of topical fluocinonide 0.1% cream in atopic dermatitis.
    Hix E; Gustafson CJ; O'Neill JL; Huang K; Sandoval LF; Harrison J; Clark A; Feldman SR
    Dermatol Online J; 2013 Oct; 19(10):20029. PubMed ID: 24139369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in treatment adherence with a 3-day course of fluocinonide cream 0.1% for atopic dermatitis.
    Yentzer BA; Ade RA; Fountain JM; Clark AR; Taylor SL; Borgerding E; Feldman SR
    Cutis; 2010 Oct; 86(4):208-13. PubMed ID: 21140931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measure of atopic dermatitis disease severity using actigraphy.
    Sandoval LF; Huang K; O'Neill JL; Gustafson CJ; Hix E; Harrison J; Clark A; Buxton OM; Feldman SR
    J Cutan Med Surg; 2014; 18(1):49-55. PubMed ID: 24377474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open-label adrenal suppression study of 0.1% fluocinonide cream in pediatric patients with atopic dermatitis.
    Schlessinger J; Miller B; Gilbert RD; Plott RT;
    Arch Dermatol; 2006 Dec; 142(12):1568-72. PubMed ID: 17178982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Good adherence and early efficacy using desonide hydrogel for atopic dermatitis: results from a program addressing patient compliance.
    Yentzer BA; Camacho FT; Young T; Fountain JM; Clark AR; Feldman SR
    J Drugs Dermatol; 2010 Apr; 9(4):324-9. PubMed ID: 20514788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency.
    Aubert-Wastiaux H; Moret L; Le Rhun A; Fontenoy AM; Nguyen JM; Leux C; Misery L; Young P; Chastaing M; Danou N; Lombrail P; Boralevi F; Lacour JP; Mazereeuw-Hautier J; Stalder JF; Barbarot S
    Br J Dermatol; 2011 Oct; 165(4):808-14. PubMed ID: 21671892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
    J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
    Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
    Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emollients improve treatment results with topical corticosteroids in childhood atopic dermatitis: a randomized comparative study.
    Szczepanowska J; Reich A; Szepietowski JC
    Pediatr Allergy Immunol; 2008 Nov; 19(7):614-8. PubMed ID: 18208463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alefacept for moderate to severe atopic dermatitis: a pilot study in adults.
    Moul DK; Routhouska SB; Robinson MR; Korman NJ
    J Am Acad Dermatol; 2008 Jun; 58(6):984-9. PubMed ID: 18395294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a novel formulation of fluocinonide 0.1% cream on skin barrier function in atopic dermatitis.
    Woods MT; Brown PA; Baig-Lewis SF; Simpson EL
    J Drugs Dermatol; 2011 Feb; 10(2):171-6. PubMed ID: 21283922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
    Murrell DF; Calvieri S; Ortonne JP; Ho VC; Weise-Riccardi S; Barbier N; Paul CF
    Br J Dermatol; 2007 Nov; 157(5):954-9. PubMed ID: 17935515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
    Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
    Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 1% Colloidal Oatmeal Cream Alone is Effective in Reducing Symptoms of Mild to Moderate Atopic Dermatitis: Results from Two Clinical Studies.
    Lisante TA; Nunez C; Zhang P; Mathes BM
    J Drugs Dermatol; 2017 Jul; 16(7):671-676. PubMed ID: 28697218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of head and neck dermatitis with ciclopiroxolamine cream--results of a double-blind, placebo-controlled study.
    Mayser P; Kupfer J; Nemetz D; Schäfer U; Nilles M; Hort W; Gieler U
    Skin Pharmacol Physiol; 2006; 19(3):153-8. PubMed ID: 16612143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-corticosteroid adherence and itch severity influence perception of itch in atopic dermatitis.
    Takeuchi S; Oba J; Esaki H; Furue M
    J Dermatol; 2018 Feb; 45(2):158-164. PubMed ID: 29168215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bilateral comparison study of pimecrolimus cream 1% and a topical medical device cream in the treatment of patients with atopic dermatitis.
    Emer JJ; Frankel A; Sohn A; Lebwohl M
    J Drugs Dermatol; 2011 Jul; 10(7):735-43. PubMed ID: 21720655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-reported outcomes from a multicenter, randomized, vehicle-controlled clinical study of MAS063DP (Atopiclair) in the management of mild-to-moderate atopic dermatitis in adults.
    Abramovits W; Hebert AA; Boguniewicz M; Kempers SE; Tschen E; Jarratt MT; Lucky AW; Cornelison RL; Swinyer LJ; Jones TM
    J Dermatolog Treat; 2008; 19(6):327-32. PubMed ID: 18728923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single-center open-label long-term comparison of tacrolimus ointment and topical corticosteroids for treatment of atopic dermatitis.
    Neumann E; Amtage D; Bruckner-Tuderman L; Mockenhaupt M
    J Dtsch Dermatol Ges; 2008 Jul; 6(7):548-53. PubMed ID: 18248495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.